Both in Pharmaceuticals
Bristol-Myers Squibb vs Teva Pharmaceutical Industries Limited
Over the past year BMY returned +35.8% and TEVA returned +105.1%; their daily moves had a correlation of 0.24.
BMY +35.8% TEVA +105.1%Growth of $1, one year, split-adjusted
| Metric | BMY | TEVA |
|---|---|---|
| Price | $62.48 | $42.09 |
| Market cap | $127.71B | $49.09B |
| Today | +1.78% | +1.50% |
| 1 month | +1.7% | +7.1% |
| 6 months | +7.3% | +20.4% |
| Year to date | +15.8% | +34.9% |
| 1 year | +46.7% | +108.1% |
| Revenue growth (YoY) | +5.7% | −0.8% |
| Gross margin | 71.3% | 52.0% |
| Net margin | 25.6% | −13.9% |
| P/E (TTM) | 13.8× | 69.4× |
| Price / sales | 2.6× | 2.8× |
| Net cash | -$32.05B | -$12.94B |
| Dividend yield | 4.03% | — |
| Volatility (60d) | 27.3% | 27.4% |
| Short % of float | 2.4% | 2.4% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).